Rapport Therapeutics, Inc. Common Stock (RAPP) is a publicly traded Healthcare sector company. As of May 21, 2026, RAPP trades at $35.69 with a market cap of $1.68B and a P/E ratio of -13.51. RAPP moved +4.04% today. Year to date, RAPP is +29.80%; over the trailing twelve months it is +249.51%. Its 52-week range spans $6.43 to $42.27. Analyst consensus is strong buy with an average price target of $51.71. Rallies surfaces RAPP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rapport Therapeutics, Inc. Common Stock (RAPP) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RAPP moved +4.04% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $35.69 |
| Market Cap | $1.68B |
| P/E Ratio | -13.51 |
| EPS | $-2.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.27 |
| 52-Week Low | $6.43 |
| Volume | 225.67K |
| Avg Volume | 0 |
| Revenue (TTM) | $20.00M |
| Net Income | $-107.28M |
| Gross Margin | 0.00% |
9 analysts cover RAPP: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $51.71.